The key takeaway that I have is that the FDA believes that T-Enox is completely Approvable at this point.
no argument there. but is mnta a buy or sell at 13 on an assumption teva gets approved may or june. my take is it is cheap, and i think the share price may rise from there on prospects of a buyout now that valuation of lovenox is behind them
Market Data 
Markets 
AI
